Aaron Dane is an Honorary Senior Lecturer in the Molecular & Clinical Pharmacology Department at the University of Liverpool and a consultant statistician to the Pharmaceutical and Biotechnology industry.
Aaron qualified with a Masters’ Degree in Medical Statistics from Leicester University in 1995 and has over 20 years of experience of in the Pharmaceutical Industry, advising on clinical development programs and interacting with regulatory agencies, most recently in the area of antibiotic development.
Aaron has been involved in discussions with regulatory authorities, particularly in Europe and the USA, to facilitate the development of new antibiotics. This has included discussions regarding alternative designs and statistical approaches to feasibly provide sufficient data for the approval of new antibiotics, including presenting on the role of Pharmacokinetic and Pharmacodynamic (PK/PD) relationships in support of regulatory approval. He has also organised a cross-industry statistical consultation with the UK Regulatory Agency to review alternative statistical approaches to make antibiotic drug development more feasible.
Aaron led a cross-industry statistical working group discussing approaches to subgroup analysis that may affect drug labelling with statisticians at the European Medicines Agency. In his early career he worked across various other therapeutic areas including the oncology, cardiovascular and clinical pharmacology areas.